Dolutegravir bulk supplier for pharma manufacturers

Dolutegravir 10 mg, 25 mg, 50 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg, 25 mg, 50 mg

Reference Brands: Tivicay(Us & EU)

Dolutegravir is an HIV-1 treatment from the integrase inhibitor class that blocks viral replication. Approved by the US FDA and EMA, it is used alone or in combination therapies like Tivicay, Triumeq, and Dovato. Known for strong efficacy and once-daily dosing.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Dolutegravir is a potent antiretroviral drug used for the treatment of HIV-1 infection. As an integrase strand transfer inhibitor (INSTI), it blocks the enzyme HIV integrase, preventing viral replication. Dolutegravir is available as a standalone medication (brand name Tivicay) and in fixed-dose combinations like Triumeq, Dovato, and Juluca. Approved by the US FDA and EMA, it is used in both adults and children. Known for its once-daily dosing, high genetic barrier to resistance, and strong efficacy, Dolutegravir is a preferred first-line HIV therapy recommended by WHO and leading HIV treatment guidelines globally. Ideal for long-term HIV management.

Dolutegravir — third party manufacturing & bulk supply

Dolutegravir 10 mg, 25 mg, 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dolutegravir is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dolutegravir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dolutegravir →

Back to Listing

Frequently Asked Questions

Dolutegravir is used for the treatment of HIV-1 infection. It helps reduce viral load, increase CD4 counts, and is often used as part of combination antiretroviral therapy. It is effective, well-tolerated, and widely used in first-line HIV treatment regimens.

Dolutegravir is made from the active substance dolutegravir sodium, which is an integrase strand transfer inhibitor (INSTI). It works by blocking the integrase enzyme that HIV needs to replicate.

The main trade name is Tivicay.

Tivicay is manufactured by ViiV Healthcare.

The generic name is Dolutegravir (commonly available as dolutegravir sodium).

The brand name is Tivicay.

It is manufactured in the UK and Europe by ViiV Healthcare, while licensed generic versions are produced in India by approved pharmaceutical manufacturers.